Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-24 @ 11:08 PM
Study NCT ID:
NCT02030834
Status:
COMPLETED
Last Update Posted:
2023-06-22
First Post:
2014-01-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas
Sponsor:
University of Pennsylvania
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-07
First Submit QC Date:
None
Study First Post Date:
2014-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-09
Results First Submit QC Date:
None
Results First Post Date:
2020-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-20
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL